We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo






  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 383

Prohibition order denied for generic desloratidine (aerius) product

  • Heenan Blaikie LLP
  • -
  • Canada
  • -
  • August 3 2010

On December 22, 2009, Justice Snider of the Federal Court dismissed Schering-Plough's application for an order preventing the Minister of Health from issuing a Notice of Compliance to Pharmascience for its generic desloratidine product until the expiry of Canadian Patent Nos. 2,325,014 (the "'014 Patent") and 2,267,136 (the "'136 Patent"

Apotex v. Pfizer Ireland Pharmaceuticals

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • October 13 2010

In a patent impeachment proceeding, the Court considered an appeal of a motion refusing to strike certain defences from the statement of defence

Eli Lilly Canada v. Novopharm Limited

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • August 4 2010

The Court of Appeal overturned the decision of the trial judge which held that the patent was invalid

Pfizer v. Ratiopharm

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • August 11 2010

The Court of Appeal dismissed Pfizer's appeal from a Trial Judge decision finding the patent at issue to be invalid

Apotex Inc. v. Pfizer Ireland Pharmaceuticals (2010 FC 968)

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • October 27 2010

Apotex appealed an Order of Prothonotary Aalto dismissing a motion to strike parts of Pfizer’s Statement of Defence relating to res judicata, estoppel (issue and collateral), comity and abuse of process

Eli Lilly Canada inc. v. Apotex Inc. (2010 FC 952)

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • October 27 2010

Apotex brought a motion to set aside an Order from 2007 granting Eli Lilly’s applications for a prohibition Order in PMNOC proceedings

Novo Nordisk v. Cobalt

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • August 18 2010

The Trial Judge dismissed an application seeking to prohibit Cobalt from coming to market with its generic repaglinide product

Novopharm Limited v. Eli Lilly and Company (2010 FC 915)

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • October 27 2010

An impeachment action was brought by Novopharm in respect of a patent for STRATTERA alleging obviousness, anticipation, utility and improper selection

Epicept Corporation v. Canada (Health) (2010 FC 956)

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • October 27 2010

The Minister of Health refused to grant data exclusivity to data from Epicept’s phase I and phase II clinical trials because CEPLENE is not an “innovative drug”

Apotex Inc. v. Shire Canada Inc. (2010 FC 1001)

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • October 27 2010

Shire appealed the Order of Prothonotary Tabib denying it permission to amend, in part, its Statement of Defence

Current Search

Suggested Facets

Author

Firm Name

Jurisdiction

Workarea

© Copyright 2006-2013 Globe Business Publishing Ltd | Cookies | Disclaimer | Privacy policy